April 13, 2016
The Future of Pharmacy
A Panel Discussion
We all know that the delivery of health care is constantly changing and facing significant challenges. Pharmacy is no exception. No matter how you slice and dice it, the world of pharmacy is changing right before our very eyes.
The role of the pharmacist in our community is going through a rapid and exciting transformation. What they do, for whom they do it and how they are compensated is changing on a seemingly daily basis. While leaders within the industry drive these changes, the pubic perception seems to be lagging far behind.
We are also fortunate to live in a progressive state when it comes to pharmacy practice. To help shed light on what this future of pharmacy truly looks like, and how it will impact us all, please join us for a dynamic conversation with todays leaders in the field of Pharmacy.
Dr. Odegard earned her Bachelor of Science in Pharmacy from the University of Washington in 1985 and her Doctor of Pharmacy degree from the UW in 1990. Currently, she is the Associate Dean of the University of Washington, School of Pharmacy for the Doctor of Pharmacy (PharmD) program and an active Professor where her teaching and research emphasize diabetes, aging and collaborative care. She is a Certified Diabetes Educator and clinical pharmacist in an interdisciplinary diabetes care clinic and provides community-based education on healthy aging to older adults. Her research is focused on the impact of pharmacy practice interventions in diabetes prevention and care, diabetes medication adherence and interprofessional collaboration and education. Dr. Odegard has published over 80 refereed manuscripts, chapters, and abstracts. Prior to her current position, Dr. Odegard was the clinical pharmacy services manager for a 200-bed community hospital and Chair of the Department of Pharmacy for the UW School of Pharmacy.
Amanda is a graduate of Purdue University College of Pharmacy. She completed her Post-Graduate Year One residency with Providence Health and Services in Portland, OR and then her Post-Graduate Year Two residency in Healthcare Administration with Virginia Mason (VM). She has been a member of the Virginia Mason team ever since. Amanda is the Pharmacy Practice Coordinator for the ambulatory clinic pharmacy team which supports five departments at eight different locations with clinical pharmacy services. She currently practices with two groups of providers at VM: General Internal Medicine – Downtown Seattle and Physical Medicine & Rehabilitation – Downtown Seattle. In addition to her clinical work, she is an active member with Washington State Pharmacy Association (WSPA) and is an Associate Professor with the University of Washington.
Don Downing is a Clinical Professor at the University Of Washington School Of Pharmacy in Seattle and Endowed Chair of the Institute for Innovative Pharmacy Practice. He and colleagues developed the country’s first pharmacist-initiated contraception, emergency contraception and immunization programs.
Prior to his appointment at the UW, Don was involved in the start-up of the Seattle Indian Health Board clinic followed by the start-up of the Puyallup Tribal Health Authority Clinic in Tacoma.
In 2015 Governor Inslee signed a bill written by Professor Downing, SB 5557, which requires all commercial health plans in Washington state to contract with pharmacists as medical providers in their health plans.
Jennifer L. Bacci, PharmD, MPH, BCACP is an Assistant Professor and the Kelley-Ross Faculty Fellow at the University of Washington School of Pharmacy. Dr. Bacci’s work focuses on the implementation and evaluation of innovative patient care models in community pharmacy. She completed her PharmD, MPH, community pharmacy residency, and community pharmacy research fellowship at the University of Pittsburgh.
Dr. Jeff Rochon earned his Doctorate of Pharmacy from the University of Washington School of Pharmacy. He completed a Community Practice Residency at Kelley-Ross Pharmacy in Seattle, WA. Over his career, Dr. Rochon has worked in hospital, clinic and community pharmacy settings.
Dr. Rochon is the Chief Executive Officer for the Washington State Pharmacy Association. Advocating for patient access to care provided by pharmacists is one of his top priorities. To achieve this end, he has worked with lawmakers, other healthcare provider organizations, patient advocacy groups, and insurers in Washington State. Dr. Rochon has been involved in the efforts to pass state legislation, including the recent passage of SB 5557 which will increase the number of pharmacists in health plan preferred provider networks ultimately leading to improved patient access to the expertise of pharmacists in hospitals, clinics, community pharmacies and nursing homes.
Ryan Oftebro is a pharmacist and Principal/CEO of the Kelley-Ross Pharmacy Group, which consists of five divisions located in Seattle, WA, including a PCAB accredited compounding pharmacy, a clinic based community pharmacy, long term care and a specialty contract pharmacy, and a clinical division dedicated to developing and implementing innovative pharmacy services. Ryan received his Pharm.D. from the University of Washington in 2003, and completed a Community Practice Residency in 2004. Ryan is has previously held a board position with the Washington State Pharmacy Association and is currently the President-elect for the American College of Apothecaries as well as a Clinical Associate Professor with the University of Washington School of Pharmacy.